市場調查報告書
商品編碼
1030260

醫藥品:全球產業年鑑 - 市場概要,競爭分析,未來預測 (到2025年)

Global Pharmaceuticals Industry Almanac - Market Summary, Competitive Analysis and Forecast to 2025

出版日期: | 出版商: MarketLine | 英文 611 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球醫藥品的市場規模,2020年達到1兆1126億美元。還有從2016年到2020年的年複合成長率(CAGR) 成為5.6%。

在世界各國新型冠狀病毒感染疾病 (COVID-19) 疫苗的需求大,提供安全有效的治療解決方案的製藥企業增加大幅收益,對市場成長有貢獻。

另一方面,因為醫藥品價格高額之下,各國政府以降低成本為目標,學名藥全球普,這成為市場成長的障礙。

本報告提供全球醫藥品產業相關分析,全球整體的市場規模、佔有率的成果值 (2016年∼2020年) 和預測值 (2025年),各地區、主要國家及各分類的詳細趨勢,主要的推動及阻礙市場要素,市場競爭情形,各國的宏觀經濟要素,主要企業的簡介、財務指標等調查。

目錄

第1章 摘要整理

  • 市場規模 (以金額為準)
  • 市場規模 (以金額為準),預測值
  • 各地區的市場區隔
  • 市場佔有率
  • 競爭情形

第2章 簡介

第3章 全球醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場未來展望
  • 波特的五力分析
  • 宏觀經濟指標

第4章 亞太地區的醫藥品市場

第5章 歐洲的醫藥品市場

第6章 法國的醫藥品市場

第7章 德國的醫藥品市場

第8章 澳洲的醫藥品市場

第9章 巴西的醫藥品市場

第10章 加拿大的醫藥品市場

第11章 中國的醫藥品市場

第12章 印度的醫藥品市場

第13章 印尼的醫藥品市場

第14章 義大利的醫藥品市場

第15章 日本的醫藥品市場

第16章 墨西哥的醫藥品市場

第17章 荷蘭的醫藥品市場

第18章 北美的醫藥品市場

第19章 俄羅斯的醫藥品市場

第20章 北歐各國的醫藥品市場

第21章 新加坡的醫藥品市場

第22章 南非的醫藥品市場

第23章 韓國的醫藥品市場

第24章 西班牙的醫藥品市場

第25章 土耳其的醫藥品市場

第26章 英國的醫藥品市場

第27章 美國的醫藥品市場

第28章 企業簡介

  • Bayer AG
  • Yangtze River Pharmaceutical Group
  • Laboratoires Pierre Fabre SA
  • Les Laboratoires Servier
  • Boehringer Ingelheim GmbH
  • AstraZeneca PLC
  • Ache Laboratorios Farmaceuticos SA
  • Hypera SA
  • EMS Sigma Pharma
  • Apotex, Inc.
  • Merck & Co., Inc.
  • Shanghai Pharmaceuticals Holding Co Ltd
  • Yunnan Baiyao Group Co Ltd
  • Guangzhou Pharmaceutical Holdings Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Ltd
  • Aurobindo Pharma Ltd
  • Dr. Reddy's Laboratories Limited
  • PT Kimia Farma Tbk
  • Novartis AG
  • A Menarini Industrie Farmaceutiche Riunite Srl
  • Chiesi Farmaceutici SpA
  • Recordati S.p.A.
  • Daiichi Sankyo Co Ltd
  • Mitsubishi Tanabe Pharma Corporation
  • Takeda Pharmaceutical Company Limited
  • Genomma Lab Internacional SAB de CV
  • Johnson & Johnson
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • Astellas Pharma Inc.
  • Adcock Ingram Holdings Ltd
  • Aspen Pharmacare Holdings Ltd
  • Chong Kun Dang Pharmaceutical Corp
  • Daewoong Pharmaceutical Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Almirall S.A.
  • Laboratorios Farmaceuticos ROVI, S.A.
  • Sanofi SA
  • Abdi Ibrahim Ilac Sanayi ve Ticaret AS
  • GlaxoSmithKline Plc
  • Pfizer Inc.

第29章 附錄

目錄
Product Code: MLIG210026-01

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).

All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2020 annual average exchange rates.

Forecast figures presented in this report are calculated using crisis scenarios for the market. The length of the pandemic and restrictions introduced by various countries are still difficult to predict. Many governments had introduced the national lockdowns and temporarily banned sales of products that are deemed "non-essential". As the length of the pandemic and its impact on this market is not certain, the data used in this report has been modeled taking forecast impacts on national economics into consideration.

The global pharmaceuticals market had total revenues of $1,112.6bn in 2020, representing a compound annual growth rate (CAGR) of 5.6% between 2016 and 2020.

Given the strong global demand for vaccines to protect citizens and control the spread of COVID-19, it is likely that pharmaceutical companies offering safe and effective therapeutic solutions will generate significant revenues, contributing to market growth.

The promotion of generic drugs has become increasingly prevalent globally as many governments seek to generate savings amid rising pharmaceutical prices, and this presents a barrier to growth in the market.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to Buy

  • What was the size of the global pharmaceuticals market by value in 2020?
  • What will be the size of the global pharmaceuticals market in 2025?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?

Table of Contents

1 EXECUTIVE SUMMARY

  • 1.1. Market value
  • 1.2. Market value forecast
  • 1.3. Geography segmentation
  • 1.4. Market share
  • 1.5. Competitive Landscape

2 Introduction

  • 2.1. What is this report about?
  • 2.2. Who is the target reader?
  • 2.3. How to use this report
  • 2.4. Definitions

3 Global Pharmaceuticals

  • 3.1. Market Overview
  • 3.2. Market Data
  • 3.3. Market Segmentation
  • 3.4. Market outlook
  • 3.5. Five forces analysis
  • 3.6. Macroeconomic Indicators

4 Pharmaceuticals in Asia-Pacific

  • 4.1. Market Overview
  • 4.2. Market Data
  • 4.3. Market Segmentation
  • 4.4. Market outlook
  • 4.5. Five forces analysis

5 Pharmaceuticals in Europe

  • 5.1. Market Overview
  • 5.2. Market Data
  • 5.3. Market Segmentation
  • 5.4. Market outlook
  • 5.5. Five forces analysis
  • 5.6. Macroeconomic Indicators

6 Pharmaceuticals in France

  • 6.1. Market Overview
  • 6.2. Market Data
  • 6.3. Market Segmentation
  • 6.4. Market outlook
  • 6.5. Five forces analysis
  • 6.6. Macroeconomic Indicators

7 Pharmaceuticals in Germany

  • 7.1. Market Overview
  • 7.2. Market Data
  • 7.3. Market Segmentation
  • 7.4. Market outlook
  • 7.5. Five forces analysis
  • 7.6. Macroeconomic Indicators

8 Pharmaceuticals in Australia

  • 8.1. Market Overview
  • 8.2. Market Data
  • 8.3. Market Segmentation
  • 8.4. Market outlook
  • 8.5. Five forces analysis
  • 8.6. Macroeconomic Indicators

9 Pharmaceuticals in Brazil

  • 9.1. Market Overview
  • 9.2. Market Data
  • 9.3. Market Segmentation
  • 9.4. Market outlook
  • 9.5. Five forces analysis
  • 9.6. Macroeconomic Indicators

10 Pharmaceuticals in Canada

  • 10.1. Market Overview
  • 10.2. Market Data
  • 10.3. Market Segmentation
  • 10.4. Market outlook
  • 10.5. Five forces analysis
  • 10.6. Macroeconomic Indicators

11 Pharmaceuticals in China

  • 11.1. Market Overview
  • 11.2. Market Data
  • 11.3. Market Segmentation
  • 11.4. Market outlook
  • 11.5. Five forces analysis
  • 11.6. Macroeconomic Indicators

12 Pharmaceuticals in India

  • 12.1. Market Overview
  • 12.2. Market Data
  • 12.3. Market Segmentation
  • 12.4. Market outlook
  • 12.5. Five forces analysis
  • 12.6. Macroeconomic Indicators

13 Pharmaceuticals in Indonesia

  • 13.1. Market Overview
  • 13.2. Market Data
  • 13.3. Market Segmentation
  • 13.4. Market outlook
  • 13.5. Five forces analysis
  • 13.6. Macroeconomic Indicators

14 Pharmaceuticals in Italy

  • 14.1. Market Overview
  • 14.2. Market Data
  • 14.3. Market Segmentation
  • 14.4. Market outlook
  • 14.5. Five forces analysis
  • 14.6. Macroeconomic Indicators

15 Pharmaceuticals in Japan

  • 15.1. Market Overview
  • 15.2. Market Data
  • 15.3. Market Segmentation
  • 15.4. Market outlook
  • 15.5. Five forces analysis
  • 15.6. Macroeconomic Indicators

16 Pharmaceuticals in Mexico

  • 16.1. Market Overview
  • 16.2. Market Data
  • 16.3. Market Segmentation
  • 16.4. Market outlook
  • 16.5. Five forces analysis
  • 16.6. Macroeconomic Indicators

17 Pharmaceuticals in The Netherlands

  • 17.1. Market Overview
  • 17.2. Market Data
  • 17.3. Market Segmentation
  • 17.4. Market outlook
  • 17.5. Five forces analysis
  • 17.6. Macroeconomic Indicators

18 Pharmaceuticals in North America

  • 18.1. Market Overview
  • 18.2. Market Data
  • 18.3. Market Segmentation
  • 18.4. Market outlook
  • 18.5. Five forces analysis

19 Pharmaceuticals in Russia

  • 19.1. Market Overview
  • 19.2. Market Data
  • 19.3. Market Segmentation
  • 19.4. Market outlook
  • 19.5. Five forces analysis
  • 19.6. Macroeconomic Indicators

20 Pharmaceuticals in Scandinavia

  • 20.1. Market Overview
  • 20.2. Market Data
  • 20.3. Market Segmentation
  • 20.4. Market outlook
  • 20.5. Five forces analysis

21 Pharmaceuticals in Singapore

  • 21.1. Market Overview
  • 21.2. Market Data
  • 21.3. Market Segmentation
  • 21.4. Market outlook
  • 21.5. Five forces analysis
  • 21.6. Macroeconomic Indicators

22 Pharmaceuticals in South Africa

  • 22.1. Market Overview
  • 22.2. Market Data
  • 22.3. Market Segmentation
  • 22.4. Market outlook
  • 22.5. Five forces analysis
  • 22.6. Macroeconomic Indicators

23 Pharmaceuticals in South Korea

  • 23.1. Market Overview
  • 23.2. Market Data
  • 23.3. Market Segmentation
  • 23.4. Market outlook
  • 23.5. Five forces analysis
  • 23.6. Macroeconomic Indicators

24 Pharmaceuticals in Spain

  • 24.1. Market Overview
  • 24.2. Market Data
  • 24.3. Market Segmentation
  • 24.4. Market outlook
  • 24.5. Five forces analysis
  • 24.6. Macroeconomic Indicators

25 Pharmaceuticals in Turkey

  • 25.1. Market Overview
  • 25.2. Market Data
  • 25.3. Market Segmentation
  • 25.4. Market outlook
  • 25.5. Five forces analysis
  • 25.6. Macroeconomic Indicators

26 Pharmaceuticals in The United Kingdom

  • 26.1. Market Overview
  • 26.2. Market Data
  • 26.3. Market Segmentation
  • 26.4. Market outlook
  • 26.5. Five forces analysis
  • 26.6. Macroeconomic Indicators

27 Pharmaceuticals in The United States

  • 27.1. Market Overview
  • 27.2. Market Data
  • 27.3. Market Segmentation
  • 27.4. Market outlook
  • 27.5. Five forces analysis
  • 27.6. Macroeconomic Indicators
  • 27.7. Country data

28 Company Profiles

  • 28.1. Bayer AG
  • 28.2. Yangtze River Pharmaceutical Group
  • 28.3. Laboratoires Pierre Fabre SA
  • 28.4. Les Laboratoires Servier
  • 28.5. Boehringer Ingelheim GmbH
  • 28.6. AstraZeneca PLC
  • 28.7. Ache Laboratorios Farmaceuticos SA
  • 28.8. Hypera SA
  • 28.9. EMS Sigma Pharma
  • 28.10. Apotex, Inc.
  • 28.11. Merck & Co., Inc.
  • 28.12. Shanghai Pharmaceuticals Holding Co Ltd
  • 28.13. Yunnan Baiyao Group Co Ltd
  • 28.14. Guangzhou Pharmaceutical Holdings Ltd
  • 28.15. Sun Pharmaceutical Industries Ltd
  • 28.16. Lupin Ltd
  • 28.17. Aurobindo Pharma Ltd
  • 28.18. Dr. Reddy's Laboratories Limited
  • 28.19. PT Kimia Farma Tbk
  • 28.20. Novartis AG
  • 28.21. A Menarini Industrie Farmaceutiche Riunite Srl
  • 28.22. Chiesi Farmaceutici SpA
  • 28.23. Recordati S.p.A.
  • 28.24. Daiichi Sankyo Co Ltd
  • 28.25. Mitsubishi Tanabe Pharma Corporation
  • 28.26. Takeda Pharmaceutical Company Limited
  • 28.27. Genomma Lab Internacional SAB de CV
  • 28.28. Johnson & Johnson
  • 28.29. Merck & Co., Inc.
  • 28.30. F. Hoffmann-La Roche Ltd
  • 28.31. Astellas Pharma Inc.
  • 28.32. Adcock Ingram Holdings Ltd
  • 28.33. Aspen Pharmacare Holdings Ltd
  • 28.34. Chong Kun Dang Pharmaceutical Corp
  • 28.35. Daewoong Pharmaceutical Co Ltd
  • 28.36. Hanmi Pharmaceuticals Co Ltd
  • 28.37. Almirall S.A.
  • 28.38. Laboratorios Farmaceuticos ROVI, S.A.
  • 28.39. Sanofi SA
  • 28.40. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
  • 28.41. GlaxoSmithKline Plc
  • 28.42. Pfizer Inc.

29 Appendix

  • 29.1. Methodology
  • 29.2. About MarketLine

List of Tables

  • Table 1: Global pharmaceuticals market value: $ billion, 2016-20
  • Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 3: Global pharmaceuticals market share: % share, by value, 2020
  • Table 4: Global pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 5: Global size of population (million), 2016-20
  • Table 6: Global gdp (constant 2005 prices, $ billion), 2016-20
  • Table 7: Global gdp (current prices, $ billion), 2016-20
  • Table 8: Global inflation, 2016-20
  • Table 9: Global consumer price index (absolute), 2016-20
  • Table 10: Global exchange rate, 2016-20
  • Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
  • Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
  • Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 15: Europe pharmaceuticals market value: $ billion, 2016-20
  • Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 17: Europe pharmaceuticals market share: % share, by value, 2020
  • Table 18: Europe pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 19: Europe size of population (million), 2016-20
  • Table 20: Europe gdp (constant 2005 prices, $ billion), 2016-20
  • Table 21: Europe gdp (current prices, $ billion), 2016-20
  • Table 22: Europe inflation, 2016-20
  • Table 23: Europe consumer price index (absolute), 2016-20
  • Table 24: Europe exchange rate, 2016-20
  • Table 25: France pharmaceuticals market value: $ billion, 2016-20
  • Table 26: France pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 27: France pharmaceuticals market share: % share, by value, 2020
  • Table 28: France pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 29: France size of population (million), 2016-20
  • Table 30: France gdp (constant 2005 prices, $ billion), 2016-20
  • Table 31: France gdp (current prices, $ billion), 2016-20
  • Table 32: France inflation, 2016-20
  • Table 33: France consumer price index (absolute), 2016-20
  • Table 34: France exchange rate, 2016-20
  • Table 35: Germany pharmaceuticals market value: $ billion, 2016-20
  • Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 37: Germany pharmaceuticals market share: % share, by value, 2020
  • Table 38: Germany pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 39: Germany size of population (million), 2016-20
  • Table 40: Germany gdp (constant 2005 prices, $ billion), 2016-20
  • Table 41: Germany gdp (current prices, $ billion), 2016-20
  • Table 42: Germany inflation, 2016-20
  • Table 43: Germany consumer price index (absolute), 2016-20
  • Table 44: Germany exchange rate, 2016-20
  • Table 45: Australia pharmaceuticals market value: $ billion, 2016-20
  • Table 46: Australia pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 47: Australia pharmaceuticals market share: % share, by value, 2020
  • Table 48: Australia pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 49: Australia size of population (million), 2016-20
  • Table 50: Australia gdp (constant 2005 prices, $ billion), 2016-20
  • Table 51: Australia gdp (current prices, $ billion), 2016-20
  • Table 52: Australia inflation, 2016-20
  • Table 53: Australia consumer price index (absolute), 2016-20
  • Table 54: Australia exchange rate, 2016-20
  • Table 55: Brazil pharmaceuticals market value: $ billion, 2016-20
  • Table 56: Brazil pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 57: Brazil pharmaceuticals market share: % share, by value, 2020
  • Table 58: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 59: Brazil size of population (million), 2016-20
  • Table 60: Brazil gdp (constant 2005 prices, $ billion), 2016-20
  • Table 61: Brazil gdp (current prices, $ billion), 2016-20
  • Table 62: Brazil inflation, 2016-20
  • Table 63: Brazil consumer price index (absolute), 2016-20
  • Table 64: Brazil exchange rate, 2016-20
  • Table 65: Canada pharmaceuticals market value: $ billion, 2016-20
  • Table 66: Canada pharmaceuticals market geography segmentation: $ billion, 2020
  • Table 67: Canada pharmaceuticals market share: % share, by value, 2020
  • Table 68: Canada pharmaceuticals market value forecast: $ billion, 2020-25
  • Table 69: Canada size of population (million), 2016-20
  • Table 70: Canada gdp (constant 2005 prices, $ billion), 2016-20
  • Table 71: Canada gdp (current prices, $ billion), 2016-20
  • Table 72: Canada inflation, 2016-20

List of Figures

  • Figure 1: Global pharmaceuticals market value: $ billion, 2016-20
  • Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2020
  • Figure 3: Global pharmaceuticals market share: % share, by value, 2020
  • Figure 4: Global pharmaceuticals market value forecast: $ billion, 2020-25
  • Figure 5: Forces driving competition in the global pharmaceuticals market, 2020
  • Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2020
  • Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2020
  • Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2020
  • Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2020
  • Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2020
  • Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
  • Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2020
  • Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
  • Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
  • Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2020
  • Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2020
  • Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2020
  • Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2020
  • Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2020
  • Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2020
  • Figure 21: Europe pharmaceuticals market value: $ billion, 2016-20
  • Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2020
  • Figure 23: Europe pharmaceuticals market share: % share, by value, 2020
  • Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2020-25
  • Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2020
  • Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2020
  • Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2020
  • Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2020
  • Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2020
  • Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2020
  • Figure 31: France pharmaceuticals market value: $ billion, 2016-20
  • Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2020
  • Figure 33: France pharmaceuticals market share: % share, by value, 2020
  • Figure 34: France pharmaceuticals market value forecast: $ billion, 2020-25
  • Figure 35: Forces driving competition in the pharmaceuticals market in France, 2020
  • Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2020
  • Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2020
  • Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
  • Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
  • Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
  • Figure 41: Germany pharmaceuticals market value: $ billion, 2016-20
  • Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
  • Figure 43: Germany pharmaceuticals market share: % share, by value, 2020
  • Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2020-25
  • Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2020
  • Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
  • Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
  • Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
  • Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
  • Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
  • Figure 51: Australia pharmaceuticals market value: $ billion, 2016-20
  • Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2020
  • Figure 53: Australia pharmaceuticals market share: % share, by value, 2020
  • Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2020-25
  • Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2020
  • Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2020
  • Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2020
  • Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2020
  • Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2020
  • Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2020
  • Figure 61: Brazil pharmaceuticals market value: $ billion, 2016-20